REPORT AN
ADVERSE EVENT

If you would like to report an adverse event that occurred with one of our products or have a product complaint, please call the appropriate phone number below.

Please contact Azurity Pharmaceuticals® at 800-461-7449, medical.information@azurity.com, or via their website for the following products that have been divested by Sebela to Azurity Pharmaceuticals:

  • GoLYTELY® (PEG-3350 and Electrolytes for Oral Solution)
  • NuLYTELY® (PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution)
  • SUFLAVE® (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution)
  • SUPREP® Bowel Prep Kit (sodium sulfate, potassium sulfate and magnesium sulfate) Oral Solution
  • SUTAB® (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets

While Miudella® (copper intrauterine system) is approved by the FDA, it is not currently marketed in the United States. For more information, please call the Medical Information Call Center at 866-246-2133.

Please contact Legacy Pharma Inc. at 800-727-7151, medinfo@legacypharmainc.com, or via their website for the following products that have been divested by Sebela to Legacy Pharma:

  • ANALPRAM HC® (hydrocortisone acetate 2.5% pramoxine HCl 1%) 2.5%
  • BRISDELLE® (paroxetine)
  • IMURAN® (azathioprine) Tablet
  • LOTRONEX® (alosetron hydrochloride) Tablets
  • MOTOFEN® (difenoxin and atropine sulfate tablets)
  • NAFTIN® (Naftifine HCl) Gel 2%
  • PRAMOSONE® (Hydrocortisone Acetate and Pramoxine Hydrochloride)
  • RIDAURA® (auranofin) Capsules

For all other products, please call 844-SEBELA1 or 844-732-3521.